Literature DB >> 7923148

Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia.

A G Hall1, P Autzen, A R Cattan, A J Malcolm, M Cole, J Kernahan, M M Reid.   

Abstract

Expression of the main classes (pi, mu, and alpha) of glutathione S-transferase (GST) was assessed in the blasts of children presenting with acute lymphoblastic leukemia using an immunohistochemical technique. Bone marrow trephine biopsies obtained at presentation from 71 cases were studied (42 boys, 29 girls; age range, 6 months-14 years; median age, 4 years) and expression was correlated with event-free survival. The period of follow-up was 12-108 months, during which time 21 patients (30%) relapsed. All the samples examined were negative for alpha class GST. Samples from 8 patients, all of whom remained in remission at the time of analysis, were found to be negative for pi class GST at presentation. Samples from 44 (patients were negative for mu class GST (62%); of these, 36 patients (82%) remained in remission. In comparison, of the 27 patients who were positive for mu class GST, only 14 (52%) remained in remission. Analysis of event-free survival demonstrated that expression of mu class GST predicts a 3-fold increased risk of relapse (95% confidence interval, 1.25-7.26). This risk factor appears to be independent of other recognized prognostic factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923148

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

Review 2.  Pharmacogenomics: a tool for improving cancer chemotherapy.

Authors:  Mariano Monzó; Alfons Navarro; Gerardo Ferrer; Rosa Artells
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

3.  The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients.

Authors:  S Ghazal-Aswad; L Hogarth; A G Hall; M George; D P Sinha; M Lind; A H Calvert; J P Sunter; D R Newell
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

4.  GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation.

Authors:  Simona Jurkovic Mlakar; Satyanarayana Chakradhara Rao Uppugunduri; Tiago Nava; Vid Mlakar; Hadrien Golay; Shannon Robin; Nicolas Waespe; Mohamed Aziz Rezgui; Yves Chalandon; Jaap Jan Boelens; Robert G M Bredius; Jean-Hugues Dalle; Christina Peters; Selim Corbacioglu; Henrique Bittencourt; Maja Krajinovic; Marc Ansari
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-09       Impact factor: 4.553

5.  Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.

Authors:  E C Wrigley; A T McGown; H Buckley; A Hall; D Crowther
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

6.  Clinical significance and biological mechanisms of glutathione S-transferase mu gene family in colon adenocarcinoma.

Authors:  Erna Guo; Haotang Wei; Xiwen Liao; Liuyu Wu; Xiaoyun Zeng
Journal:  BMC Med Genet       Date:  2020-06-15       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.